Articles with public access mandates - Keith A Johnson - Swedish Research CouncilLearn more
NoteFor this mandate, articles should be available from specific locations.
OverallDFGFWOSFIDSTFWFFNRSNIHGovernment of SpainGovernment of ItalyNSFCFCTEuropean CommissionSTFCAcademy of FinlandDOECSIRNSFNKFIBELSPOMESTDOTKAMTACASHelmholtzBMBFSNSFTUBITAKNCNCIHRDoDFAPESPMRCNHMRCNIHRSwedish Research CouncilARCNSERCHHMIWellcomeFRQSNWOUK Research & InnovationKnut and Alice Wallenberg FoundationGovernment of ArgentinaDFFDNRFNRFARRSRCNDoris Duke Charitable FoundationResearch Grants Council, Hong KongRoyal Society UKParkinson's Foundation, USAAHAGenome CanadaINSERMMarianne and Marcus Wallenberg FoundationAlzheimers's UKBBSRCEPSRCZonMwANRUSAIDHSFBanking Foundation "la Caixa"HRBCancer Research UKCanada First Research Excellence FundGatesFordNASAVAEMBLBHFDMTState of CalifoniaFRQNTNMRCMichael J Fox FoundationMQ Mental Health ResearchCZI
Available based on mandate: 11
Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease
D Aguillon, S Langella, Y Chen, JS Sanchez, Y Su, C Vila‐Castelar, ...
Alzheimer's & Dementia 19 (6), 2585-2594, 2023
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
R Ossenkoppele, A Pichet Binette, C Groot, R Smith, O Strandberg, ...
Nature medicine 28 (11), 2381-2387, 2022
Amyloid and Tau PET positive cognitively unimpaired individuals: Destined to decline?
R Ossenkoppele, AP Binette, C Groot, R Smith, O Strandberg, S Palmqvist, ...
medRxiv, 2022.05. 23.22275241, 2022
Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non‐demented individuals with autosomal‐dominant Alzheimer's disease
E Guzmán‐Vélez, H Zetterberg, JT Fox‐Fuller, C Vila‐Castelar, ...
Alzheimer's & Dementia 17 (5), 813-821, 2021
Dedifferentiation of caudate functional connectivity and striatal dopamine transporter density predict memory change in normal aging
A Rieckmann, KA Johnson, RA Sperling, RL Buckner, T Hedden
Proceedings of the National Academy of Sciences 115 (40), 10160-10165, 2018
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ...
Neurology 85 (14), 1240-1249, 2015
Brain structure and function as mediators of the effects of amyloid on memory
N Mattsson, PS Insel, PS Aisen, W Jagust, S Mackin, M Weiner, ...
Neurology 84 (11), 1136-1144, 2015
Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression
A Caroli, A Prestia, S Galluzzi, C Ferrari, WM Van Der Flier, ...
Neurology 84 (5), 508-515, 2015
The road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations
E Cavedo, S Lista, Z Khachaturian, P Aisen, P Amouyel, K Herholz, ...
The journal of prevention of Alzheimer's disease 1 (3), 181, 2014
Age and amyloid-related alterations in default network habituation to stimulus repetition
P Vannini, T Hedden, JA Becker, C Sullivan, D Putcha, D Rentz, ...
Neurobiology of aging 33 (7), 1237-1252, 2012
Publication and funding information is determined automatically by a computer program